EU, Germany expect Novavax deliveries to begin this week

The European Commission and the German government said on Monday they expect deliveries of the Novavax COVID-19 vaccine Nuvaxovid to begin over the course of this week. Novavax's recombinant protein vaccine uses a more established technology than mRNA, the novel method behind the two most commonly used COVID-19 vaccines in Germany made by Pfizer/BioNTech and Moderna.